Literature DB >> 29852343

Comorbid depressive and anxiety symptoms and the risk of type 2 diabetes: Findings from the Lifelines Cohort Study.

Sonya S Deschênes1, Rachel J Burns2, Norbert Schmitz3.   

Abstract

BACKGROUND: Prior studies indicate that depression is a risk factor for type 2 diabetes (T2D), though there is considerable heterogeneity in reported estimates. Identifying homogeneous subgroups of depression strongly associated with T2D may be beneficial. This study examined associations between depression and anxiety comorbidity with the risk of T2D.
METHODS: 78,025 participants from the Lifelines Cohort Study (age range = 30-75 years) without diabetes at baseline were included in this study. The Mini-International Neuropsychiatric Interview assessed depressive and anxiety symptoms at baseline. Incident T2D was assessed by self-report or hemoglobin A1c levels during an approximately 3.8-year follow-up period. Risk of T2D was compared across four groups (no depressive or anxiety symptoms, depressive symptoms alone, anxiety symptoms alone, comorbid depressive/anxiety symptoms) using mixed effects logistic regression analyses adjusted for sociodemographic, lifestyle, and cardiometabolic characteristics.
RESULTS: 1,096 participants developed diabetes. Compared to those without depressive or anxiety symptoms (n = 74,467), those with comorbid depressive and anxiety symptoms (n = 743) were more likely to develop T2D (n = 28, OR = 2.12, 95% CI = 1.22-3.68). Depressive symptoms alone (n = 650) and anxiety symptoms alone (n = 2,165) were not significantly associated with T2D (n = 23 and n = 24, respectively, developed diabetes). Those with comorbid symptoms were also more likely to develop T2D compared to those with depressive symptoms alone (OR = 2.86, 95% CI = 1.25-6.54). LIMITATIONS: Depressive and anxiety symptom assessments were based on a screening tool. Hemoglobin A1c data were only available for a subset of participants.
CONCLUSIONS: Depression with comorbid anxiety may be a subgroup of depression that is strongly associated with the risk of T2D.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Cohort study; Comorbidity; Depression; Depression subtypes; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29852343     DOI: 10.1016/j.jad.2018.05.029

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

1.  Role of glucocorticoid receptor phosphorylation-mediated synaptic plasticity in anxiogenic and depressive behaviors induced by monosodium glutamate.

Authors:  Wen Zhu; Feng Yang; Xiaofang Cai; Wen Zhang; Jingsi Zhang; Min Cai; Xiangting Li; Jun Xiang; Dingfang Cai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-05-22       Impact factor: 3.000

2.  Risk Factors and Prevalence of Suicide Attempt in Patients with Type 2 Diabetes in the Mexican Population.

Authors:  Tania Guadalupe Gómez-Peralta; Thelma Beatriz González-Castro; Ana Fresan; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Mario Villar-Soto; Yazmín Hernández-Díaz; María Lilia López-Narváez; Jorge L Ble-Castillo; Nonanzit Pérez-Hernández; José Manuel Rodríguez-Pérez
Journal:  Int J Environ Res Public Health       Date:  2018-06-07       Impact factor: 3.390

3.  Mental Health among Spanish Adults with Diabetes: Findings from a Population-Based Case-Controlled Study.

Authors:  Marta Lopez-Herranz; Rodrigo Jiménez-García; Zichen Ji; Javier de Miguel-Diez; David Carabantes-Alarcon; Clara Maestre-Miquel; José J Zamorano-León; Ana López-de-Andrés
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.